Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$0.3511 4.43%
Market Cap
$29.2M
Price Target
Refer to Report
Volume
1.8M
52wk Range
$0.29 - $3.39
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.